— Uxin Limited (NASDAQ: UXIN) reported Q3 2019 loss of RMB0.30, or $0.04 per share, vs. $0.14 expected.
— Revenues grew 33.4% to RMB461.4 million, or $65.2 million, vs. $135 million expected.
— 2C revenue was RMB327.5 million, or $46.3 million, up 246.9% year-over-year.
— 2B revenue was RMB71.7 million, or $10.1 million, down 62.5% year-over-year.
— 2C transaction volume increased 107.3% to 23,566 units.
— 2B transaction volume decreased 66.6% to 30,658 units.
— 2C GMV increased to RMB2,828 million, representing a year-over-year growth of 110.0%.
— 2B GMV decreased to RMB1,537 million, representing a year-over-year decline of 64.1%.
— Q4 2019 total revenues are estimated to be RMB540 million to RMB560 million.
— Q4 2019 adjusted loss from continuing operations are projected to be RMB150 million to RMB170 million.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Deals and R&D in focus as Johnson & Johnson (JNJ) gears up for Q1 earnings
For Johnson & Johnson (NYSE: JNJ), investments in the pipeline and exiting lower priority businesses remain central to its strategy in the new fiscal year. The healthcare behemoth is in
Earnings preview: What to expect when these major banks report Q1 2025 results
The leading players in the banking industry are set to report their earnings results for the first quarter of 2025 over this week and the next. While majors JPMorgan Chase
Walgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today. Sales increased 4.1% year-over-year to $38.6 billion. Sales growth was 4.7% on a constant currency basis. The
